Below is a detailed analysis of the quarterly data for Zen Technologies Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
For Sales, as of Mar 2025, the value is 294.00 Cr.. The value appears strong and on an upward trend. It has increased from 142.00 Cr. (Dec 2024) to 294.00 Cr., marking an increase of 152.00 Cr..
For Expenses, as of Mar 2025, the value is 199.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 105.00 Cr. (Dec 2024) to 199.00 Cr., marking an increase of 94.00 Cr..
For Operating Profit, as of Mar 2025, the value is 94.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Dec 2024) to 94.00 Cr., marking an increase of 57.00 Cr..
For OPM %, as of Mar 2025, the value is 32.00%. The value appears strong and on an upward trend. It has increased from 26.00% (Dec 2024) to 32.00%, marking an increase of 6.00%.
For Other Income, as of Mar 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Dec 2024) to 24.00 Cr., marking an increase of 2.00 Cr..
For Interest, as of Mar 2025, the value is 4.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.00 Cr. (Dec 2024) to 4.00 Cr., marking an increase of 1.00 Cr..
For Depreciation, as of Mar 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 3.00 Cr..
For Profit before tax, as of Mar 2025, the value is 112.00 Cr.. The value appears strong and on an upward trend. It has increased from 53.00 Cr. (Dec 2024) to 112.00 Cr., marking an increase of 59.00 Cr..
For Tax %, as of Mar 2025, the value is 24.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Dec 2024) to 24.00%, marking a decrease of 4.00%.
For Net Profit, as of Mar 2025, the value is 85.00 Cr.. The value appears strong and on an upward trend. It has increased from 39.00 Cr. (Dec 2024) to 85.00 Cr., marking an increase of 46.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 9.41. The value appears strong and on an upward trend. It has increased from 4.28 (Dec 2024) to 9.41, marking an increase of 5.13.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
×
Quarterly Chart
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 3:23 pm
Metric
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
46
79
53
62
39
92
147
50
54
161
430
931
Expenses
46
58
48
50
41
70
83
42
52
110
253
617
Operating Profit
1
21
4
12
-2
23
64
8
2
51
177
314
OPM %
1%
27%
8%
19%
-5%
24%
43%
16%
4%
32%
41%
34%
Other Income
4
3
5
4
4
3
2
3
5
9
16
58
Interest
2
2
2
3
2
5
3
1
1
2
2
9
Depreciation
2
2
4
4
3
4
4
4
4
4
7
10
Profit before tax
0
20
3
9
-3
17
59
6
2
54
184
352
Tax %
18%
21%
21%
20%
-86%
-13%
-3%
28%
-9%
30%
30%
25%
Net Profit
0
16
2
7
-0
19
61
4
2
38
129
263
EPS in Rs
0.01
2.04
0.30
0.96
-0.05
2.49
7.84
0.52
0.25
4.73
15.38
29.12
Dividend Payout %
858%
2%
33%
16%
-198%
12%
5%
19%
39%
4%
6%
7%
×
Profit & Loss Yearly Chart
YoY Net Profit Growth
Year
2015-2016
2016-2017
2017-2018
2019-2020
2020-2021
2021-2022
2022-2023
2023-2024
2024-2025
YoY Net Profit Growth (%)
-87.50%
250.00%
-100.00%
221.05%
-93.44%
-50.00%
1800.00%
239.47%
103.88%
Change in YoY Net Profit Growth (%)
0.00%
337.50%
-350.00%
321.05%
-314.50%
43.44%
1850.00%
-1560.53%
-135.60%
Zen Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2024-2025.
Growth
Compounded Sales Growth
10 Years:
28%
5 Years:
45%
3 Years:
159%
TTM:
116%
Compounded Profit Growth
10 Years:
33%
5 Years:
34%
3 Years:
394%
TTM:
106%
Stock Price CAGR
10 Years:
37%
5 Years:
105%
3 Years:
126%
1 Year:
54%
Return on Equity
10 Years:
18%
5 Years:
20%
3 Years:
24%
Last Year:
25%
Last Updated: Unknown
No data available for the Balance Sheet data table.
Reserves and Borrowings Chart
Cash Flow
Month
Month
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Cash from Operating Activity +
10
0
43
5
19
-44
64
13
-44
99
21
-146
Cash from Investing Activity +
-8
0
-9
30
-12
7
-11
-18
-43
-3
-82
-862
Cash from Financing Activity +
-7
0
-3
-8
-5
5
-21
10
87
-18
-6
1,017
Net Cash Flow
-5
0
30
26
3
-32
32
5
0
78
-67
8
Free Cash Flow Chart
Financial Efficiency Indicators
Month
Mar 2013
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Debtor Days
127
90
276
56
120
212
290
110
128
133
150
143
Inventory Days
212
295
225
242
237
1,181
496
97
396
625
368
355
Days Payable
53
63
47
52
89
355
106
48
114
147
33
70
Cash Conversion Cycle
286
322
455
246
267
1,038
681
159
410
612
484
429
Working Capital Days
236
143
281
138
150
80
295
180
548
830
56
152
ROCE %
6%
2%
16%
3%
9%
-0%
14%
32%
3%
1%
17%
47%
Financial Efficiency Indicators Chart
Share Holding Pattern
Month
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Promoters
60.19%
60.19%
60.19%
60.19%
60.19%
60.14%
57.45%
57.45%
55.07%
55.07%
55.07%
51.26%
FIIs
0.35%
0.29%
0.32%
0.33%
0.30%
1.29%
3.47%
4.84%
4.65%
3.84%
3.09%
5.72%
DIIs
0.00%
0.00%
0.01%
0.11%
0.11%
0.15%
0.21%
0.15%
3.09%
3.31%
3.37%
8.05%
Public
39.46%
39.52%
39.13%
39.03%
39.05%
37.82%
38.11%
36.80%
36.42%
37.15%
37.94%
34.49%
Others
0.00%
0.00%
0.35%
0.35%
0.35%
0.61%
0.76%
0.76%
0.76%
0.62%
0.53%
0.47%
No. of Shareholders
96,275
1,14,705
1,18,806
1,16,610
1,22,339
1,08,420
1,27,208
1,59,766
1,61,995
1,70,421
2,01,211
2,29,479
Shareholding Pattern Chart
No. of Shareholders
This stock is not held by any mutual fund.
ROCE Trend
EPS Trend
Key Financial Ratios
Month
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
FaceValue
1.00
1.00
1.00
1.00
1.00
Basic EPS (Rs.)
32.07
15.45
5.39
0.25
0.39
Diluted EPS (Rs.)
32.07
15.34
5.20
0.25
0.39
Cash EPS (Rs.)
34.86
16.56
7.05
0.93
0.97
Book Value[Excl.RevalReserv]/Share (Rs.)
188.36
55.48
32.13
27.05
26.49
Book Value[Incl.RevalReserv]/Share (Rs.)
188.36
55.48
32.13
27.05
26.49
Revenue From Operations / Share (Rs.)
107.83
52.34
27.52
8.77
6.87
PBDIT / Share (Rs.)
47.84
23.29
10.04
1.25
1.31
PBIT / Share (Rs.)
46.13
22.13
9.28
0.64
0.68
PBT / Share (Rs.)
44.98
22.15
9.02
0.41
0.54
Net Profit / Share (Rs.)
33.16
15.41
6.28
0.32
0.34
NP After MI And SOA / Share (Rs.)
31.04
15.22
5.38
0.24
0.39
PBDIT Margin (%)
44.36
44.49
36.49
14.26
19.04
PBIT Margin (%)
42.77
42.29
33.72
7.33
9.97
PBT Margin (%)
41.71
42.32
32.77
4.73
7.98
Net Profit Margin (%)
30.74
29.44
22.83
3.74
5.07
NP After MI And SOA Margin (%)
28.78
29.07
19.52
2.84
5.69
Return on Networth / Equity (%)
16.47
28.50
17.70
0.95
1.52
Return on Capital Employeed (%)
23.07
38.70
22.12
1.72
2.55
Return On Assets (%)
13.67
17.03
9.02
0.53
1.39
Long Term Debt / Equity (X)
0.02
0.00
0.00
0.02
0.01
Total Debt / Equity (X)
0.03
0.00
0.02
0.06
0.01
Asset Turnover Ratio (%)
0.69
0.71
0.39
0.18
0.22
Current Ratio (X)
6.57
2.29
2.69
3.84
13.35
Quick Ratio (X)
6.09
1.66
2.34
3.49
11.84
Inventory Turnover Ratio (X)
2.39
1.58
1.93
1.00
0.64
Dividend Payout Ratio (NP) (%)
0.00
1.30
1.85
40.05
102.21
Dividend Payout Ratio (CP) (%)
0.00
1.21
1.62
11.66
39.44
Earning Retention Ratio (%)
0.00
98.70
98.15
59.95
-2.21
Cash Earning Retention Ratio (%)
0.00
98.79
98.38
88.34
60.56
Interest Coverage Ratio (X)
41.63
85.79
19.59
6.50
9.53
Interest Coverage Ratio (Post Tax) (X)
29.85
56.71
12.77
2.89
3.54
Enterprise Value (Cr.)
12462.13
7886.73
2457.39
1565.48
585.38
EV / Net Operating Revenue (X)
12.80
17.93
11.23
22.44
10.71
EV / EBITDA (X)
28.85
40.30
30.77
157.39
56.26
MarketCap / Net Operating Revenue (X)
13.70
18.25
11.90
23.34
11.32
Retention Ratios (%)
0.00
98.69
98.14
59.94
-2.21
Price / BV (X)
7.84
17.89
10.79
7.82
3.03
Price / Net Operating Revenue (X)
13.70
18.25
11.90
23.34
11.32
EarningsYield
0.02
0.01
0.01
0.00
0.01
After reviewing the key financial ratios for Zen Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:
For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
For Basic EPS (Rs.), as of Mar 25, the value is 32.07. This value is within the healthy range. It has increased from 15.45 (Mar 24) to 32.07, marking an increase of 16.62.
For Diluted EPS (Rs.), as of Mar 25, the value is 32.07. This value is within the healthy range. It has increased from 15.34 (Mar 24) to 32.07, marking an increase of 16.73.
For Cash EPS (Rs.), as of Mar 25, the value is 34.86. This value is within the healthy range. It has increased from 16.56 (Mar 24) to 34.86, marking an increase of 18.30.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 188.36. It has increased from 55.48 (Mar 24) to 188.36, marking an increase of 132.88.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 188.36. It has increased from 55.48 (Mar 24) to 188.36, marking an increase of 132.88.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 107.83. It has increased from 52.34 (Mar 24) to 107.83, marking an increase of 55.49.
For PBDIT / Share (Rs.), as of Mar 25, the value is 47.84. This value is within the healthy range. It has increased from 23.29 (Mar 24) to 47.84, marking an increase of 24.55.
For PBIT / Share (Rs.), as of Mar 25, the value is 46.13. This value is within the healthy range. It has increased from 22.13 (Mar 24) to 46.13, marking an increase of 24.00.
For PBT / Share (Rs.), as of Mar 25, the value is 44.98. This value is within the healthy range. It has increased from 22.15 (Mar 24) to 44.98, marking an increase of 22.83.
For Net Profit / Share (Rs.), as of Mar 25, the value is 33.16. This value is within the healthy range. It has increased from 15.41 (Mar 24) to 33.16, marking an increase of 17.75.
For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 31.04. This value is within the healthy range. It has increased from 15.22 (Mar 24) to 31.04, marking an increase of 15.82.
For PBDIT Margin (%), as of Mar 25, the value is 44.36. This value is within the healthy range. It has decreased from 44.49 (Mar 24) to 44.36, marking a decrease of 0.13.
For PBIT Margin (%), as of Mar 25, the value is 42.77. This value exceeds the healthy maximum of 20. It has increased from 42.29 (Mar 24) to 42.77, marking an increase of 0.48.
For PBT Margin (%), as of Mar 25, the value is 41.71. This value is within the healthy range. It has decreased from 42.32 (Mar 24) to 41.71, marking a decrease of 0.61.
For Net Profit Margin (%), as of Mar 25, the value is 30.74. This value exceeds the healthy maximum of 10. It has increased from 29.44 (Mar 24) to 30.74, marking an increase of 1.30.
For NP After MI And SOA Margin (%), as of Mar 25, the value is 28.78. This value exceeds the healthy maximum of 20. It has decreased from 29.07 (Mar 24) to 28.78, marking a decrease of 0.29.
For Return on Networth / Equity (%), as of Mar 25, the value is 16.47. This value is within the healthy range. It has decreased from 28.50 (Mar 24) to 16.47, marking a decrease of 12.03.
For Return on Capital Employeed (%), as of Mar 25, the value is 23.07. This value is within the healthy range. It has decreased from 38.70 (Mar 24) to 23.07, marking a decrease of 15.63.
For Return On Assets (%), as of Mar 25, the value is 13.67. This value is within the healthy range. It has decreased from 17.03 (Mar 24) to 13.67, marking a decrease of 3.36.
For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.02, marking an increase of 0.02.
For Total Debt / Equity (X), as of Mar 25, the value is 0.03. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.03, marking an increase of 0.03.
For Asset Turnover Ratio (%), as of Mar 25, the value is 0.69. It has decreased from 0.71 (Mar 24) to 0.69, marking a decrease of 0.02.
For Current Ratio (X), as of Mar 25, the value is 6.57. This value exceeds the healthy maximum of 3. It has increased from 2.29 (Mar 24) to 6.57, marking an increase of 4.28.
For Quick Ratio (X), as of Mar 25, the value is 6.09. This value exceeds the healthy maximum of 2. It has increased from 1.66 (Mar 24) to 6.09, marking an increase of 4.43.
For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.39. This value is below the healthy minimum of 4. It has increased from 1.58 (Mar 24) to 2.39, marking an increase of 0.81.
For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 1.30 (Mar 24) to 0.00, marking a decrease of 1.30.
For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 1.21 (Mar 24) to 0.00, marking a decrease of 1.21.
For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 98.70 (Mar 24) to 0.00, marking a decrease of 98.70.
For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 98.79 (Mar 24) to 0.00, marking a decrease of 98.79.
For Interest Coverage Ratio (X), as of Mar 25, the value is 41.63. This value is within the healthy range. It has decreased from 85.79 (Mar 24) to 41.63, marking a decrease of 44.16.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 29.85. This value is within the healthy range. It has decreased from 56.71 (Mar 24) to 29.85, marking a decrease of 26.86.
For Enterprise Value (Cr.), as of Mar 25, the value is 12,462.13. It has increased from 7,886.73 (Mar 24) to 12,462.13, marking an increase of 4,575.40.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 12.80. This value exceeds the healthy maximum of 3. It has decreased from 17.93 (Mar 24) to 12.80, marking a decrease of 5.13.
For EV / EBITDA (X), as of Mar 25, the value is 28.85. This value exceeds the healthy maximum of 15. It has decreased from 40.30 (Mar 24) to 28.85, marking a decrease of 11.45.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 13.70. This value exceeds the healthy maximum of 3. It has decreased from 18.25 (Mar 24) to 13.70, marking a decrease of 4.55.
For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 98.69 (Mar 24) to 0.00, marking a decrease of 98.69.
For Price / BV (X), as of Mar 25, the value is 7.84. This value exceeds the healthy maximum of 3. It has decreased from 17.89 (Mar 24) to 7.84, marking a decrease of 10.05.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 13.70. This value exceeds the healthy maximum of 3. It has decreased from 18.25 (Mar 24) to 13.70, marking a decrease of 4.55.
For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
×
Profitability Ratios (%)
Liquidity Ratios
Liquidity Ratios (%)
Interest Coverage Ratios (%)
Valuation Ratios
Fair Value
Fair Value of Zen Technologies Ltd as of July 1, 2025 is: 2,396.98
Calculation basis:
Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.
As of July 1, 2025, Zen Technologies Ltd is Undervalued by 26.49% compared to the current share price 1,895.00
Intrinsic Value of Zen Technologies Ltd as of July 1, 2025 is: 5,361.69
Calculation basis:
Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.
This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.
As of July 1, 2025, Zen Technologies Ltd is Undervalued by 182.94% compared to the current share price 1,895.00
Last 5 Year EPS CAGR: 123.69%
*Investments are subject to market risks
Strength and Weakness
Unable to fetch valid data for stock valuation.
Stock Analysis
Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Zen Technologies Ltd:
Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
ROE%: 16.47% (Industry Average ROE: 16.9%)
ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
Stock P/E: 65.1 (Industry average Stock P/E: 79.16)
Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
Total Debt / Equity: 0.03
Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions. Stock Rating:
About the Company - Qualitative Analysis
Zen Technologies Ltd. is a Public Limited Listed company incorporated on 29/06/1993 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L72200TG1993PLC015939 and registration number is 015939. Currently Company is involved in the business activities of Manufacture of optical instruments and equipment. Company's Total Operating Revenue is Rs. 930.67 Cr. and Equity Capital is Rs. 9.03 Cr. for the Year ended 31/03/2025.
FAQ: Stock data is invalid or not in the correct format.
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Zen Technologies Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
